Replies to post #395979 on Amarin Corp Plc (AMRN)

[couldbebetter]

Zip, My belief is if a BP such as Pfizer owned AMRN these issues would be
handled much better. Too bad for CVD patients that BP did not own this
much earlier as I believe they would be more competent in getting Vascepa
more widely approved. I wonder what game plan Alex Denner has in store
once he makes his move. (Whatever that might be.) I certainly hope he
will find an acquirer for AMRN at least so more CVD patients would benefit
from better "handling" of reimbursement issues.

[CaptBeer]

That's because Insurance companies know that customers switch insurers on average every 12 months. Then treatment costs become someone else's problem.